Initiator Pharma AS (OSTO:INIT) OCF Margin %: 0.00% (As of Mar. 2026)


OSTO:INIT Initiator Pharma AS OSTO:INIT
18 GF Score
Price kr2.82
! 1 Warning Sign
View Full Analysis

What is Initiator Pharma AS OCF Margin %?

Initiator Pharma AS OSTO:INIT +1.44% 18 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates OSTO:INIT with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 960 Biotechnology companies, Initiator Pharma AS ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Initiator Pharma AS's Cash Flow from Operations for the three months ended in Mar. 2026 was kr-17.02 Mil. Initiator Pharma AS's Revenue for the three months ended in Mar. 2026 was kr0.00 Mil. Therefore, Initiator Pharma AS's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Initiator Pharma AS's current OCF Yield % is -20.58%.

The historical rank and industry rank for Initiator Pharma AS's OCF Margin % or its related term are showing as below:


OSTO:INIT's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Initiator Pharma AS OCF Margin % Related Terms

Initiator Pharma AS OCF Margin % Historical Data

* Premium members only.

The historical data trend for Initiator Pharma AS's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Initiator Pharma AS OCF Margin % Chart

Initiator Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Initiator Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:INIT
18GF Score
Initiator Pharma AS OSTO:INIT
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Initiator Pharma AS OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Initiator Pharma AS's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-25.829/0
= %

Initiator Pharma AS's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-17.024/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Initiator Pharma AS (OSTO:INIT) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Initiator Pharma AS and its competitors. According to the industry distribution chart, Initiator Pharma AS ranks #999999 out of 960 companies in the Biotechnology industry.
Is Initiator Pharma AS's OCF Margin % too high?
Initiator Pharma AS's current OCF Margin % is 0.00%. Based on the distribution chart, Initiator Pharma AS ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Initiator Pharma AS has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Initiator Pharma AS's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Initiator Pharma AS ranks #999999 out of 960 companies for OCF Margin %. This places Initiator Pharma AS in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Initiator Pharma AS and its competitors. Initiator Pharma AS's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Initiator Pharma AS stock overvalued right now?
Initiator Pharma AS (OSTO:INIT) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Initiator Pharma AS's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Initiator Pharma AS (OSTO:INIT), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Initiator Pharma AS Business Description

Address Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma AS is a Danish clinical-stage life science company developing drugs that target key unmet medical needs within the central and peripheral nervous system. Its pipeline consists of three clinical programs: IP2018 and pudafensine for the treatment of erectile dysfunction of psychogenic and organic origin, respectively.
18GF Score

Get the complete analysis for OSTO:INIT

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.82
Price